Back to Search
Start Over
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103).
- Source :
- AIDS Weekly; 3/3/2025, p41-41, 1p
- Publication Year :
- 2025
Details
- Language :
- English
- ISSN :
- 15324524
- Database :
- Complementary Index
- Journal :
- AIDS Weekly
- Publication Type :
- Periodical
- Accession number :
- 183317461